1. Evaluation of Clinical and Pathological Factors to Predict High Risk of Recurrence in Patients With Stage II Colon Cancer
- Author
-
Jonathan M. Loree, Yaling Yin, Brent Parker, Winson Y. Cheung, Janine M. Davies, Breanne Cadham, and Sharlene Gill
- Subjects
Oncology ,medicine.medical_specialty ,Multivariate analysis ,Colorectal cancer ,Population ,Risk Factors ,Internal medicine ,medicine ,Humans ,In patient ,education ,Pathological ,Neoplasm Staging ,education.field_of_study ,biology ,business.industry ,Gastroenterology ,Prognosis ,medicine.disease ,Transthyretin ,Time to recurrence ,Colonic Neoplasms ,biology.protein ,Neoplasm Recurrence, Local ,business ,Stage ii colon cancer - Abstract
The ability to predict patients with stage II colon cancer at high risk of recurrence is currently limited to certain clinicopathologic factors. This population-based study reviewed various prognostic factors to identify those associated with worse time to recurrence (TTR) and improved disease specific survival (DSS), and to subsequently develop a prognostic index (PI) to identify high risk cancers. Multivariate analyses revealed factors significant for TTR and DSS. A PI derived from the TTR risk factors identified 3 risk groups using 5-year rate without relapse: 88% for low-risk, 81% for intermediate-risk, and 59% for high-risk. This model was better at identifying high risk patients than using equally weighted standard risk factors.
- Published
- 2022